Back to companies

Haisco Pharmaceutical Group Co Ltd: Overview

Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drugs. The company's product portfolio comprises narcotic analgesics, endocrine system drugs, enteral and parenteral nutrition drugs, neuropsychiatric drugs, cardiovascular drugs, cancer-related drugs, digestive liver disease drugs, and others. Its product range covers anesthesia and analgesia, parenteral nutrition, tumor antiemetic, liver disease treatment, digestive system, nervous system, anti-infection, and other sub-fields. The company conducts research and development of drugs for anesthesia and analgesia, diabetes and complications, tumors, and neuralgia among others. It operates offices in Shannan and Chengdu. Haisco Pharma is headquartered in Shannan, Tibet, China.

Headquarters China

Address No. 17, Sanxiang Avenue, Zedang Town, Shannan, 856000


Telephone 86 893 7834865

No of Employees 4,247

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange 002653 (SHE)

Revenue (2021) $430.0M -16.7% (2021 vs 2020)

EPS XXX

Net Income (2021) XXX -45.8% (2021 vs 2020)

Market Cap* $3.2B

Net Profit Margin (2021) XXX -34.9% (2021 vs 2020)

* As of and is in US$

Access premium data and analytics for Haisco Pharmaceutical Group Co Ltd

90+

Clinical Trials

Determine Haisco Pharmaceutical Group Co Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

40+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Haisco Pharmaceutical Group Co Ltd’s relevant decision makers and contact details.

20+

Pipeline Drugs

Identify which of Haisco Pharmaceutical Group Co Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Marketed Drugs

Understand Haisco Pharmaceutical Group Co Ltd’s commercialized product portfolio to stay one step ahead of the market.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

4

Install Base

Install Base provides a holistic and a granular view of the IT product/service deployments from leading vendors. Explore IT infrastructure categories, solution and product/service areas deployed by a prospect.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Haisco Pharmaceutical Group Co Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Subscribe to Company Analytics & gain access to premium industry data & analytics Subscribe to Company Analytics & gain access to premium industry data & analytics Start Here

Products and Services

Products Services
Narcotic Analgesics Services
Endocrine System Drugs Research and Development Services
Enteral and Parenteral Nutrition Drugs
XXX
XXX
XXX
Subscribe to Company Analytics for access to more products & services data Subscribe to Company Analytics for access to more products & services data Learn More
Image for loader

Competitor Comparison

Key Parameters Haisco Pharmaceutical Group Co Ltd Jiangsu Hengrui Medicine Co Ltd Zhangzhou Pien Tze Huang Pharmaceutical Co Ltd Luye Pharma Group Ltd Gpro Titanium Industry Co., Ltd.
Headquarters China China China China China
City Shannan Lianyungang Zhangzhou Yantai Nanjing
State/Province - Jiangsu Fujian Shandong Jiangsu
No. of Employees 4,247 24,491 2,591 4,800 1,044
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
Wang Junmin Chairman Executive Board 2010 54
Zheng Wei Director; Deputy General Manager Executive Board 2020 52
Fan Xiulian Managing Director Executive Board 2019 59
Duan Peng Chief Financial Officer Senior Management 2016 48
Wang Meng Deputy General Manager; Secretary Senior Management 2015 37
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Non Dignissim Eros Proin vel Convallis 2022 XX
Gain more insight into company management & employee structure with Company Analytics Gain more insight into company management & employee structure with Company Analytics Subscribe
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company Analytics

Contact the team or request a demo to find out how our data can drive your business forward

Why are you leaving?